Table 4.
Characteristics of patients according to prognosis
| Characteristic | No relapse | Relapse | P valueb |
|---|---|---|---|
| Age (years)a | 63 (10) | 69.0 (14.5) | 0.100 |
| Sex (% male) | 68.8% | 66.7% | 0.817 |
| Distance between the tumor and the anus (cm)a | 8 (7) | 7 (5) | 0.492 |
| Patients who received NACRT (%) | 47.7% | 57.6% | 0.320 |
| Number of lymph nodes harvesteda | 13 (7) | 13 (9) | 0.818 |
| Number of metastatic lymph nodesa | 0 (1) | 1 (4) | 0.003 |
| Lymph node ratioa | 0 (0.09) | 0.13 (0.32) | 0.001 |
| Patients without metastatic lymph nodes (%) | 69.7% | 42.4% | 0.004 |
| Patients with TRG 4 (%) | 25.0% | 21.4% | 0.780 |
NACRT neoadjuvant chemoradiotherapy, TRG tumor regression grade
aResults are reported as median (interquartile range)
bP values < 0.05 are reported in bold